Free Trial

Cytek Biosciences (CTKB) Short Interest Ratio & Short Volume

$5.96
-0.14 (-2.30%)
(As of 05/20/2024 ET)

Cytek Biosciences Short Interest Data

Current Short Interest
7,850,000 shares
Previous Short Interest
7,470,000 shares
Change Vs. Previous Month
+5.09%
Dollar Volume Sold Short
$47.18 million
Short Interest Ratio
11.2 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
131,270,000 shares
Float Size
119,190,000 shares
Short Percent of Float
6.59%
Today's Trading Volume
453,221 shares
Average Trading Volume
723,517 shares
Today's Volume Vs. Average
63%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Cytek Biosciences ?

Sign up to receive the latest short interest report for Cytek Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CTKB Short Interest Over Time

CTKB Days to Cover Over Time

CTKB Percentage of Float Shorted Over Time

Cytek Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20247,850,000 shares $47.18 million +5.1%6.6%11.2 $6.01
4/15/20247,470,000 shares $44.97 million -24.9%6.3%10.8 $6.02
3/31/20249,950,000 shares $66.76 million +16.9%8.4%13.8 $6.71
3/15/20248,510,000 shares $59.14 million +9.2%7.1%11.6 $6.95
2/29/20247,790,000 shares $59.98 million +4.6%6.3%10.2 $7.70
2/15/20247,450,000 shares $64.96 million -2.5%6.3%9.1 $8.72
1/31/20247,640,000 shares $57.68 million No Change6.6%8.1 $7.55
1/15/20247,640,000 shares $62.72 million +5.2%6.6%7.1 $8.21
12/31/20237,260,000 shares $66.21 million -5.2%6.3%6.5 $9.12
12/15/20237,660,000 shares $69.55 million -3.8%6.6%7.1 $9.08
11/30/20237,960,000 shares $55.24 million -5.0%6.9%7.2 $6.94
11/15/20238,380,000 shares $47.85 million +5.8%7.2%7.8 $5.71
10/31/20237,920,000 shares $33.34 million +0.6%6.8%8.1 $4.21
10/15/20237,870,000 shares $39.51 million -2.8%6.7%8.9 $5.02
9/30/20238,100,000 shares $44.71 million -31.8%6.9%9.5 $5.52
9/15/202311,880,000 shares $83.16 million +0.5%10.4%14.2 $7.00
8/31/202311,820,000 shares $89.83 million +2.7%10.3%14.8 $7.60
8/15/202311,510,000 shares $100.25 million -4.2%10.1%15.2 $8.71
7/31/202312,020,000 shares $107.70 million +4.9%11.0%12.3 $8.96
7/15/202311,460,000 shares $103.25 million +9.4%10.5%8.3 $9.01
6/30/202310,480,000 shares $89.50 million +11.4%9.6%7.6 $8.54
6/15/20239,410,000 shares $81.68 million +8.4%8.6%6.8 $8.68
5/31/20238,680,000 shares $67.79 million -22.6%8.0%6.5 $7.81
5/15/202311,210,000 shares $81.61 million +66.1%10.3%8.3 $7.28
4/30/20236,750,000 shares $77.49 million +3.7%7.2%6.2 $11.48
4/15/20236,510,000 shares $66.27 million +15.2%6.0%9.6 $10.18
3/31/20235,650,000 shares $51.92 million -2.4%5.2%8.2 $9.19
3/15/20235,790,000 shares $56.16 million +1.1%5.3%8.3 $9.70
2/28/20235,730,000 shares $59.02 million +4.4%5.3%8.8 $10.30
2/15/20235,490,000 shares $65.50 million +7.7%5.2%8.8 $11.93
1/31/20235,100,000 shares $61.46 million +28.5%5.6%8.3 $12.05
1/15/20233,970,000 shares $43.63 million +9.7%4.3%6.6 $10.99
12/30/20223,620,000 shares $36.96 million +4.3%4.3%6.5 $10.21
12/15/20223,470,000 shares $37.44 million +20.9%4.1%5.9 $10.79
11/30/20222,870,000 shares $36.99 million +3.6%3.4%4.4 $12.89
11/15/20222,770,000 shares $40.86 million -14.8%3.3%4.1 $14.75
10/31/20223,250,000 shares $50.44 million -13.8%4.4%4.8 $15.52
10/15/20223,770,000 shares $54.25 million -9.4%5.0%5.6 $14.39
9/30/20224,160,000 shares $61.24 million +51.3%5.6%6.2 $14.72
9/15/20222,750,000 shares $38.20 million +3.8%3.7%4 $13.89
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.
8/31/20222,650,000 shares $30.87 million -4.0%3.6%4.3 $11.65
8/15/20222,760,000 shares $41.32 million -12.1%3.7%4 $14.97
7/31/20223,140,000 shares $40.19 million -2.2%4.2%4.2 $12.80
7/15/20223,210,000 shares $38.62 million -10.1%4.0%4.2 $12.03
6/30/20223,570,000 shares $38.31 million -9.6%4.5%4.7 $10.73
6/15/20223,950,000 shares $38.99 million -4.8%4.9%5 $9.87
5/31/20224,150,000 shares $40.30 million -7.8%5.2%3.8 $9.71
5/15/20224,500,000 shares $42.21 million +22.0%5.6%3.8 $9.38
4/30/20223,690,000 shares $34.87 million -4.9%4.9%3 $9.45
4/15/20223,880,000 shares $40.24 million -6.7%5.1%3.2 $10.37
3/31/20224,160,000 shares $44.84 million +321.4%5.5%3.6 $10.78
3/15/2022987,100 shares $12.03 million +9.5%1.3%0.9 $12.19
2/28/2022901,700 shares $12.30 million +44.7%1.2%1.3 $13.64
2/15/2022623,300 shares $9.35 million -30.0%0.8%1.2 $15.00
1/31/2022890,500 shares $12.97 million -12.7%1.2%2.9 $14.56
1/15/20221,020,000 shares $14.01 million +7.4%1.4%5.1 $13.74
12/31/2021949,900 shares $15.50 million +42.0%1.3%5.2 $16.32
12/15/2021669,000 shares $12.27 million +15.7%0.9%3.4 $18.34
11/30/2021578,100 shares $11.66 million -16.8%0.8%2.4 $20.17
11/15/2021695,100 shares $16.10 million -7.3%0.9%2.7 $23.16
10/29/2021749,600 shares $17.10 million -3.2%0.9%2.9 $22.81
10/15/2021774,200 shares $18.63 million +31.6%1.0%2.6 $24.07
9/30/2021588,500 shares $12.60 million +206.2%0.7%1.5 $21.41
9/15/2021192,200 shares $5.37 million +330.0%0.2%0.5 $27.93
8/31/202144,700 shares $1.02 million -51.2%0.2%0.1 $22.78
8/13/202191,600 shares $1.89 million No Change0.1%0.2 $20.67

CTKB Short Interest - Frequently Asked Questions

What is Cytek Biosciences' current short interest?

Short interest is the volume of Cytek Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 7,850,000 shares of CTKB short. 6.59% of Cytek Biosciences' shares are currently sold short. Learn More on Cytek Biosciences' current short interest.

What is a good short interest ratio for Cytek Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTKB shares currently have a short interest ratio of 11.0. Learn More on Cytek Biosciences's short interest ratio.

Which institutional investors are shorting Cytek Biosciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cytek Biosciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Cytek Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.59% of Cytek Biosciences' floating shares are currently sold short.

Is Cytek Biosciences' short interest increasing or decreasing?

Cytek Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 7,850,000 shares, an increase of 5.1% from the previous total of 7,470,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cytek Biosciences' float size?

Cytek Biosciences currently has issued a total of 131,270,000 shares. Some of Cytek Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cytek Biosciences currently has a public float of 119,190,000 shares.

How does Cytek Biosciences' short interest compare to its competitors?

6.59% of Cytek Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Cytek Biosciences: Standard BioTools Inc. (3.09%), EyePoint Pharmaceuticals, Inc. (12.67%), Quanterix Co. (3.84%), Pacific Biosciences of California, Inc. (19.39%), Valneva SE (0.08%), Prothena Co. plc (12.55%), Allogene Therapeutics, Inc. (32.03%), Nautilus Biotechnology, Inc. (1.96%), Myriad Genetics, Inc. (6.57%), Olink Holding AB (publ) (1.99%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Cytek Biosciences stock?

Short selling CTKB is an investing strategy that aims to generate trading profit from Cytek Biosciences as its price is falling. CTKB shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cytek Biosciences?

A short squeeze for Cytek Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTKB, which in turn drives the price of the stock up even further.

How often is Cytek Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTKB, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CTKB) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners